Flavonoid-rich dietary supplements' influence on heart failure

Wild-Type Food in Health Promotion and Disease Prevention: The Columbus Concept

Volumn , Issue , 2008, Pages 435-442

  Zibadi, Sherma ^a   Larson, Douglas F ^b   Watson, Ronald Ross ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

bioflavanoids; fruit; heart disease; Pycnogenol

Indexed keywords

EID: 84884026816     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-330-1_29     Document Type: Chapter

References (47)

1. American Heart Association. Heart Disease and Stroke Statistics-2006 Update. Dallas, TX, American Heart Association, 2006.
2. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult-summary article: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). J Am Coll Cardiol 2005;46:1116-1143.
3. Ferrara R, Mastrorilli F, Pasanisi G, et al. Neurohormonal modulation in chronic heart failure. Eur Heart J 2002;4 (Suppl D):D3-D11.
4. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 2000;35:569-582.
5. Krstevska M, Dzhekova-Stojkova S, Bosilkova G. Menopause, coronary artery disease and antioxidants. Clin Chem Lab Med 2001;39:641-644.
6. Lopez FA, Casado S. Heart failure, redox alterations, and endothelial dysfunction. Hypertension 2001;38:1400-1405.
7. Dhalla AK, Hill M, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 1996;28:506-514.
8. Bauersachs J, Bouloumie A, Fraccarollo D, Hu K, Busse R, Ertl G. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: Role of enhanced vascular superoxide production. Circulation 1999;100:292-298.
9. Keith M, Geranmayegan A, Sole MJ, et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 1998;31:1352-1356.
10. Singh RB, Rastogi SS, Verma R, Laxmi B, Singh R, Ghosh S, Niaz MA. Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: Results of one year follow up. BMJ 1992;304:1015-1019.
11. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study. Circulation 1999;99:779-785.
12. Ross JA, Kasum CM. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002;22:19-34.
13. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 1993;342:1007-1011.
14. Hertog MGL, Kromhout D, Aravanis C, et al. Flavonoid intake and long-Term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 1995;155:381-386.
15. Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: A cohort study. BMJ 1996;312:478-481.
16. Yochum L, Kushi LH, Meyer K, Folsom AR. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol 1999;149:943-949.
17. Fuhrman B, Aviram M. Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr Opin Lipidol 2001;12:41-48.
18. Vita JA. Polyphenols and cardiovascular disease: Effects on endothelial and platelet function. Am J Clin Nutr 2005;81(1 Suppl):292S-297S.
19. Cook NC, Samman S. Flavonoids- chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem 1996;7:66-76.
20. Rice-Evans CA, Miller NJ, Paganga G. Structure-Antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biol and Med 1996;20:933-956.
21. Bone K. Clinical Applications of Ayurvedic and Chinese Herbs. Warwick, Queensland, Australia. Phytotherapy Press, 1996, pp. 131-133.
22. Kapoor LD. Handbook of Ayurvedic Medicinal Plants. Boca Raton, FL. CRC Press; 1990:319-320.
23. Bharani A, Ganguly A, Bhargava KD. Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure. Int J Cardiol 1995;49:191-199.
24. Dwivedi S, Jauhari R. Beneficial effects of Terminalia arjuna in coronary artery disease. Indian Heart J 1997;49:507-510.
25. Zhang ZZ, Liang XM, Zhang Q, Lu PZ. Characterization and recognition key components in Astragalus membranaceus (Chinese). Yao Xue Xue Bao 2001;36:523-527.
26. Zhou ZL, Yu P, Lin D. Study on effect of Astragalus injection in treating congestive heart failure. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001;21:747-749.
27. Zhang JG, Yang N, He H, Wei GH, Gao DS, Wang XL, Wang XZ, Song GY. Effect of Astragalus injection on plasma levels of apoptosis-related factors in aged patients with chronic heart failure. Chin J Integr Med 2005;11:187-190.
28. Ma J, Peng A, Lin S. Mechanisms of the therapeutic effect of astragalus membranaceus on sodium and water retention in experimental heart failure. Chin Med J (Engl) 1998;111:17-23.
29. Veveris M, Koch E, Chatterjee SS. Crataegus special extract WS 1442 improves cardiac function and reduces infarct size in a rat model of prolonged coronary ischemia and reperfusion. Life Sci 2004;74:1945-1955.
30. Schroder D, Weiser M, Klein P. Efficacy of a homeopathic Crataegus preparation compared with usual therapy for mild (NYHA II) cardiac insufficiency: Result of an observational cohort study. Eur J Heart Fail 2003;5:319-326.
31. Habs M. Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: Heart failure treatment with and without Hawthorn special extract WS 1442. Forsch Komplementarmed Klass Naturheilkd. 2004;11(1 Suppl):36-39.
32. Pittler MH, Ernst E. Hawthorn extract for treating chronic heart failure: Meta-Analysis of randomized trials. Am J Med 2003;114:665-674.
33. Tankanow R, Tamer HR, Streetman DS, et al. Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha). J Clin Pharmacol 2003;43:637-642.
34. Corder R, Warburton RC, Khan NQ, Brown RE, Wood EG, Lees DM. The procyanidin-induced pseudo laminar shear stress response: A new concept for the reversal of endothelial dysfunction. Clin Sci 2004;107:513-517.
35. Stangl V, Lorenz M, Stangl K. The role of tea and tea flavonoids in cardiovascular health. Mol Nutr Food Res 2006;50:218-228.
36. Priyadarshi S, Valentine B, Han C, et al. Effect of green tea extract on cardiac hypertrophy following 5/6 nephrectomy in the rat. Kidney Int 2003;63:1785-1790.
37. Rohdewald P. A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther 2002;40:158-168.
38. Devaraj S, Vega-Lopez S, Kaul N, Schonlau F, Rohdewald P, Jialal I. Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile. Lipids 2002;37:931-934.
39. Zibadi S, Yu Q, Rohdewald P, Larson DF, Watson RR. Impact of Pycnogenol on cardiac extracellular matrix remodeling induced by L-NAME administration to old mice. Cardiovasc Texicol 2007. In press.
40. Omoni AO, Aluko RE. Soybean foods and their benefits: Potential mechanisms of action. Nutr Rev 2005;63:272-283.
41. McCue P, Shetty K. Health benefits of soy isoflavonoids and strategies for enhancement: A review. Crit Rev Food Sci Nutr 2004;44:361-367.
42. Ma SF, Guan SD, Zhu Y. Effect of soybean isoflavones on heart function of rats with adriamycininduced heart failure. Zhong Xi Yi Jie He Xue Bao 2004;2:278-280.
43. Souzeau E, Belanger S, Picard S, Deschepper CF. Dietary isoflavones during pregnancy and lactation provide cardioprotection to offspring rats in adulthood. Am J Physiol Heart Circ Physiol. 2005;289:H715-H721.
44. Stauffer BL, Konhilas JP, Luczak ED, Leinwand LA. Soy diet worsens heart disease in mice. J Clin Invest 2006;116:209-216.
45. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem 1999;274:21, 491-21, 494.
46. Yu Q, Watson RR, Marchalonis JJ, Larson DF. A role for T lymphocytes in mediating cardiac diastolic function.Am J Physiol Heart Circ Physiol 2005;289:H643-H651.
47. Howard BV, Kritchevsky D. Phytochemicals and cardiovascular disease. A statement for healthcare professionals from the American Heart Association. Circulation. 1997;95:2591-2593. Review.